Skip to content

PHARMAGEN, INC.

CIK 0001470915

← back to feed
Revenue (TTM)
$5.55M
+13.0% YoY Q1 May 2014
Net Income (TTM)
−$4.4M
−116.5% YoY Q1 May 2014
EPS Diluted (TTM)
—
Q1 May 2014
Gross Margin
56.6%
Q1 May 2014
Operating Margin
-36.9%
Q1 May 2014
Net Margin
-79.3%
Q1 May 2014
Free Cash Flow (TTM)
−$558.82K
Q1 May 2014
Cash
$264.67K
Q1 May 2014
Total Debt
$520K
Q1 May 2014
Shares Outstanding
517.08M sh
Q1 May 2014

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings